Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a128665d3cd6c39c0b8fa1a85174b169 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4704 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2005-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d3a509e7a6c5db7de3b8b1c70a24f99 |
publicationDate |
2007-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2007117100-A1 |
titleOfInvention |
Biomarker for determining predisposition and/or prognosis of hepatocellular carcinoma |
abstract |
Disclosed herein are a method for determining predisposition to hepatocellular carcinoma (HCC) in a subject having or suspected to have a hepatic nodule, in particular one infected with at least one of hepatitis B virus and hepatitis C virus, and a method for prognostic evaluation of a subject having or suspected to have HCC, in which Wnt-1 is used as a biomarker of HCC. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102397337-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010291602-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008085526-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9012162-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200012852-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8889364-B2 |
priorityDate |
2005-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |